EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis

EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis

Viral oncogenes may drive cellular metabolic reprogramming to modulate the normal epithelia cell malignant transformation. Understanding the viral oncogene–mediated signaling transduction dysregulation that involves in metabolic reprogramming may provide new therapeutic targets for virus-associated...

Full description

Bibliographic Details
Main Authors:	Tingting Yang, Chanping You, Shuhui Meng, Zhengquan Lai, Weipeng Ai, Jun Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	EBV infection metabolic reprogramming nasopharyngeal carcinoma NPC pathogenesis therapeutic strategies
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.935205/full

Similar Items

The Role of NK Cells in EBV Infection and EBV-Associated NPC
by: Yi Tian Png, et al.
Published: (2021-02-01)

EBV DNA methylation profiles and its application in distinguishing nasopharyngeal carcinoma and nasal NK/T-cell lymphoma
by: Cao-Li Tang, et al.
Published: (2024-01-01)

SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target
by: Oscar Emanuel, et al.
Published: (2021-09-01)

The Application of Emodin Treatment on Nasopharyngeal Carcinoma Therapy
by: Chung-Chun Wu, et al.
Published: (2024-02-01)

Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer
by: Hoi-Lam Ngan, et al.
Published: (2018-06-01)

Long-Term Outcomes of Nasopharyngeal Carcinoma by Epstein–Barr Virus Status in the Chinese Population: A Multicenter Investigation
by: Yudi Xiong, et al.
Published: (2023-04-01)

Increased Prevalence of EBV Infection in Nasopharyngeal Carcinoma Patients: A Six-Year Cross-Sectional Study
by: Abdullah E. Al-Anazi, et al.
Published: (2023-01-01)

BHRF1 Enhances EBV Mediated Nasopharyngeal Carcinoma Tumorigenesis through Modulating Mitophagy Associated with Mitochondrial Membrane Permeabilization Transition
by: Shujie Song, et al.
Published: (2020-05-01)

Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts
by: Po-Ju Lee, et al.
Published: (2022-08-01)

Prevalence of Epstein Barr Virus in biopsy specimens of nasopharyngeal carcinoma from Serbian patients
by: Banko Ana, et al.
Published: (2014-01-01)

The prognostic value of integration of pretreatment serum amyloid A (SAA)–EBV DNA (S-D) grade in patients with nasopharyngeal carcinoma
by: Jianpei Li, et al.
Published: (2020-01-01)

Link of Nasopharyngeal Carcinoma and Epstein-Barr Virus
by: Sugiyanto Sugiyanto, et al.
Published: (2018-10-01)

Etiology and management of nasopharyngeal hemorrhage after radiotherapy for nasopharyngeal carcinoma
by: Zhan J, et al.
Published: (2019-03-01)

Primary nasopharyngeal carcinoma with cerebrospinal fluid EBV positivity: A case report and mini literature review
by: Jinli Feng, et al.
Published: (2024-03-01)

MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma
by: Sumei Wang, et al.
Published: (2019-08-01)

BZLF1 Expression of EBV is correlated with PARP1 Regulation on Nasopharyngeal Carcinoma Tissues
by: Wahyu nur laili fajri, Ahmad Rofi'i, Fatchiyah Fatchiyah
Published: (2013-04-01)

EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer
by: Kousho Wakae, et al.
Published: (2020-10-01)

LMP1-EBV Gene Deletion Mutations and HLA Genotypes of Nasopharyngeal Cancer Patients in Vietnam
by: Cua Thi Hong Trinh, et al.
Published: (2023-01-01)

The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients
by: Stefano Cavalieri, et al.
Published: (2022-12-01)

A Distinct Anti-EBV DNase Profile in Patients with Undifferentiated Nasopharyngeal Carcinoma Compared to Classical Antigens
by: Hamid Melouli, et al.
Published: (2023-10-01)

Prevalence of Nasopharyngeal Carcinoma in Patients with Dermatomyositis: A Systematic Review and Meta-Analysis
by: Ahmad Adebayo Irekeola, et al.
Published: (2021-04-01)

Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients
by: Marco Bologna, et al.
Published: (2020-10-01)

Treatment of Nasopharyngeal Carcinoma by Using Deep X-Ray Therapy
by: Raad . A Al-Obaydi, et al.
Published: (2012-06-01)

Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma
by: Ye Q, et al.
Published: (2021-07-01)

Immune cells markers within local tumor microenvironment are associated with EBV oncoprotein in nasopharyngeal cancer
by: Soehartati A. Gondhowiardjo, et al.
Published: (2022-08-01)

Association Between Serum Cotinine Level and Serological Markers of Epstein–Barr Virus in Healthy Subjects in South China Where Nasopharyngeal Carcinoma Is Endemic
by: Qian-Yi Yang, et al.
Published: (2019-09-01)

Effect of radiotherapy interruption on nasopharyngeal cancer
by: Fangrui Zhao, et al.
Published: (2023-04-01)

Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma
by: Wei Chen, et al.
Published: (2015-03-01)

Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma
by: Pui Yan Siak, et al.
Published: (2021-07-01)

Prognostic value of plasma EBV DNA for nasopharyngeal cancer patients during treatment with intensity-modulated radiation therapy and concurrent chemotherapy
by: Lertbutsayanukul Chawalit, et al.
Published: (2018-04-01)

Molecular Detection of Epstein - Barr virus in Nasopharyngeal Carcinoma among Sudanese population
by: Ali Edris, et al.
Published: (2016-11-01)

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens
by: Marija Rozman, et al.
Published: (2022-07-01)

Epstein–Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma
by: Eveline Hoebe, et al.
Published: (2018-03-01)

Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma
by: Han Zhou, et al.
Published: (2020-04-01)

Genomic and microbial factors affect the prognosis of anti-pd-1 immunotherapy in nasopharyngeal carcinoma
by: Liqin Xu, et al.
Published: (2022-08-01)

Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma
by: Kai-Bin Yang, et al.
Published: (2021-03-01)

Third Epidemiological Analysis of Nasopharyngeal Carcinoma in the Central Region of Japan from 2006 to 2015
by: Masafumi Kanno, et al.
Published: (2019-08-01)

Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways
by: Hsin-Pai Li, et al.
Published: (2023-12-01)

The EBV-Encoded Oncoprotein, LMP1, Recruits and Transforms Fibroblasts via an ERK-MAPK-Dependent Mechanism
by: Alexandra M Davis, et al.
Published: (2021-08-01)

Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy
by: Jin-Hao Yang, et al.
Published: (2021-05-01)